Relmada Therapeutics, Inc.

NASDAQ:RLMD

Biotechnology

Healthcare
$3.11 -0.97%

-$0.06 today

Market cap
$331.82M
Beta
0.39
P/E (TTM)
-9.6
EPS (TTM)
-$0.68
52W Low $0.52High $8.00

Volume 1.71M

Average 1.24M

Private 5-step workspace

Build a RLMD investment thesis

Turn Relmada Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.